The intense inflammation that accompanies shingles can harm the brain, researchers say. Vaccination may be able to prevent ...
Novo Nordisk in 2020 launched pivotal trials of its GLP-1 drug semaglutide in Alzheimer's patients based on studies in ...
For years, Los Altos resident Kim Wilford watched Alzheimer’s Disease rob her beloved mother-in-law of her memories, spirit ...
To meet this challenge head-on, University of California San Diego researchers and clinicians are tackling Alzheimer’s at every angle — from the earliest detection to groundbreaking therapies, novel ...
Eisai (ESAIY) and Biogen (BIIB) “announced that the latest data confirming the pharmacological effect of lecanemab, an anti-Abeta protofibril ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
Novo Nordisk (NVO) reportedly defended its decision to test Semaglutide, its GLP-1 therapy, in Alzheimer’s disease on Tuesday ...
A large new trial falls short of experts’ expectations for combating the neurodegenerative disease. But there could still be ...
Final data from the ELAD trial showed that treatment with liraglutide (Saxenda, Victoza) in people with mild to moderate ...
Valiltramiprosate is a brain-penetrant small molecule that blocks amyloid from aggregating into toxic oligomers, which are ...
A recent study revealed that obesity may accelerate the progression of Alzheimer’s disease.Scientists discovered that blood ...
Poor regulation of blood flow to the brain and sleep problems/irregular sleep patterns are known risk factors for cognitive decline and dementia, including Alzheimer's disease, so these new results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback